MRI and PET in patients with locally advanced rectal cancer treated with preoperative radiochemotherapy.

MRI and PET in patients with locally advanced rectal cancer treated with preoperative radiochemotherapy. - Imaging in rectal cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON33842

Enrollment

Registered

2010-01-08

Start date

2010-03-04

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

rectal cancer rectal carcinoma

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Biopsy proven adenocarcinoma Rectal tumor

Exclusion criteria

Exclusion criteria: Patients who meet exclusion criteria for MRI at 3T Patients who meet exclusion criteria for Gadolinium intravenous contrast (kidney function GFR

Design outcomes

Primary

Measure	Time frame
Explorative study to determine the feasibility to apply anatomical and functional MRI and FDG-PET in the evaluation of treatment response after radiochemotherapy treatment for locally advanced rectal cancer compared to the pathological specimen as gold standard.	—

Secondary

Measure	Time frame
Determination of the most useful imaging variables and optimal timing sequence for the imaging modalities (diffusion weighted MRI, perfusion MRI and FDG-PET) to evaluate the tumour response on radiochemotherapy.	—

Countries

Netherlands

Outcome results